We are thrilled to be hosting our Seventh Annual Hamptons CEO Roundtable Conference. On behalf of our clients, we are grateful to the investment community for making unique events such as these possible. Your interest and participation are essential to The Trout Group’s ability to provide excellent service to our clients.
For more information and / or to register, please login.
Topping Rose House
1 Bridgehampton-Sag Harbor Turnpike
The Southampton Inn
91 Hill St
mention Trout Group Rate
Charles G. Drake, MD, PhD
Dr. Drake has a Ph.D. in immunology, whose work focuses on understanding and fighting advanced-stage cancers with the immune system. Currently he is the director of genitourinary oncology and associate director for clinical research at the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York. He is known for rapidly incorporating discoveries made in the research lab into innovative clinical trials, including anti-tumor vaccines. His most recent work has focused on the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer.
Dr. Drake served as the co-director of the Cancer Immunology Program at Johns Hopkins Kimmel Cancer Center. He was also a professor of oncology, urology, and immunology. Clinically, he served as a co-director of the Prostate Cancer Multi-Disciplinary Clinic.
Axel Hoos, M.D., Ph.D.
Dr. Axel Hoos is the senior vice president of Oncology R&D at GlaxoSmithKline Pharmaceuticals (GSK). Previously, while he was the Global Medical Lead in Immunology/Oncology at Bristol-Myers Squibb (BMS), Dr. Hoos helped played a pivotal role in the approval of the first FDA-approved checkpoint immunotherapy, the anti-CTLA-4 ipilimumab. In his current role, he directs discovery and development at GSK and is focused on building their immuno-oncology portfolio across antibodies, small molecules, bispecific molecules, and cell and gene therapies.
In addition to being a member of CRI’s Scientific Advisory Council, Dr. Hoos serves as chairman of the Cancer Immunotherapy Consortium (CIC) Steering Committee.
Harry Fisch, M.D.
Dr. Harry Fisch is a board certified urologist at New York Presbyterian Hospital/Weill Medical College of Cornell University. He is one of the nation's leaders in the diagnosis and treatment of Men's health issues as well as sexuality and fertility problems in couples. Internationally renowned, he has pioneered microsurgical techniques for disorders associated with male infertility such as vasectomy reversal and varicocele repair. He has been named to the “Best Doctors in America" and "New York Magazine Top Doctor" the past 9 years. He regularly appears on the Dr. Oz show as a medical expert on Men's Health.
His work has been frequently cited in a variety of publications, including USA Today, The New York Times, and The Washington Post. He has appeared on television's 60 Minutes, 20/20, CNN and Today, among many others.
Brett Giroir, M.D.
Brett P. Giroir, M.D. is an internationally recognized expert in medicine, public health, and life sciences innovation. On May 25, 2017 President nominated Dr. Giroir to be the Medical Director in the Regular Corps of the United States Public Health Service and United States Assistant Secretary for Health.
Giroir has led major initiatives for academic institutions, global corporations, and the U.S. Departments of Defense, Health and Human Services, and Veterans Affairs. He is President and CEO of ViraCyte, LLC, a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe infections and currently serves as Senior Fellow at the Texas Medical Center Health Policy Institute and Strategic Advisor for the Texas Medical Center Innovation Institute (TMCx). He is a member of the Texas Task Force for Infectious Disease Preparedness and Response (charted initially by the Governor to respond to Texas Ebola cases), Adjunct Professor of Pediatrics, Tropical Medicine, and Medical Ethics and Health Policy at the Baylor College of Medicine.